By Chris Wack

Perrigo Company Plc (PRGO) said Thursday it is buying the branded over-the-counter rights to Prevacid from GlaxoSmithKline (GSK).

Perrigo said under the terms of the agreement, it will have the exclusive rights to market, sell and distribute Prevacid 24HR in the U.S. OTC market.

Financial terms of the agreement weren't disclosed.

Prevacid 24HR treats frequent heartburn occurring two or more days a week.

Write to Chris Wack at chris.wack@wsj.com

(END) Dow Jones Newswires

September 05, 2019 09:09 ET (13:09 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Gsk Charts.
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Gsk Charts.